Discoveries
Cancer
Cancer
We are rapidly demystifying cancers, exposing the molecular mechanisms underlying tumors and leading the search for the next generation of targeted cancer therapies. We see a future where every cancer and every patient has a cure.

Discoveries

IN THIS ISSUE

Nature
09/2023

Reducing stress on T cells makes them better cancer fighters

Even for killer T cells—specialized immune cells—seeking and destroying cancer cells around the clock can be exhausting. In a new study, Professor Susan Kaech, first author Anna-Maria Globig, and colleagues discovered that the body’s sympathetic stress response (“fight-or-flight”) hormones can exhaust killer T cells in varying cancer types in mouse and human tissue samples—and that exhaustion can be inhibited with beta-blockers. Their discovery demonstrates the potential benefit of pairing beta-blockers with existing immunotherapies to improve cancer treatment by bolstering killer T cell function.

Read News Release

Science
09/2023

Rewiring tumor mitochondria enhances the immune system’s ability to recognize and fight cancer

Immunotherapy, which uses the body’s own immune system to fight cancer, is an effective treatment option, yet many patients do not respond to it. Thus, cancer researchers are seeking new ways to optimize immunotherapy so that it is more effective for more people. Now, Professors Susan Kaech and Gerald Shadel, co-first authors Kailash Chandra Mangalhara and Karthik Varanasi, and colleagues have found that manipulating an early step in energy production in mitochondria—the cell’s powerhouses—reduces melanoma tumor growth and enhances the immune response in mice. In the future, this manipulation of mitochondrial energy production may be leveraged to create new cancer therapeutics that are less harmful for mitochondria and cells.

Read News Release

Nature Communications
09/2023

Unleashing the power of AI to track animal behavior

Movement offers a window into how the brain operates and controls the body. Methods for tracking human and animal movement have come a long way, with current cutting-edge methods utilizing artificial intelligence to automatically track parts of the body as they move. However, training these models is still time-intensive and limited by the need for researchers to manually mark each body part hundreds to thousands of times. Associate Professor Eiman Azim, first author Daniel Butler, and colleagues have created GlowTrack, a noninvasive movement-tracking method that uses fluorescent dye markers to train artificial intelligence. GlowTrack is robust, time-efficient, and high-definition—capable of tracking a single digit on a mouse’s paw or hundreds of landmarks on a human hand.

Read News Release

Science
10/2023

“A new era in brain science”: Unveiling human brain cell atlas

Professor Joseph Ecker, Research Professor Margarita Behrens, co-first authors Jingtian Zhou and Wei Tian, and other Salk colleagues and global collaborators analyzed more than half a million brain cells from three human brains to assemble an atlas of hundreds of cell types that make up a human brain in unprecedented detail. The massive scientific collaboration is a part of the National Institutes of Health’s BRAIN Initiative, an effort launched in 2014 to describe the full plethora of cells in mammalian brains. More detailed work on a larger number of brains, Ecker says, will pave the way toward a better understanding of how certain brain cell types can malfunction in brain disorders and diseases.

Read News Release

Nature Communications
11/2023

Genetic architecture may be key to using peacekeeping immune cells to treat autoimmunity or fight cancer

Regulatory T cells are specialized immune cells that suppress the immune response and prevent the body from attacking its own cells. The behavior of these cells is influenced by chromatin architecture (the 3D shape of chromosomes) and which genes are accessible to proteins like Foxp3. Now, Professor Ye Zheng, Assistant Professor Jesse Dixon, co-first authors Dongsung Lee and Zhi Liu, and colleagues have discovered that Foxp3 is essential for creating the unique chromatin architecture of regulatory T cells and, in turn, promoting their immune suppressive function.

Read News Release

Cell Reports
11/2023

Repairing nerve cells after injury and in chronic disease

Each year in the United States there are more than 3 million cases of peripheral neuropathy, wherein nerves outside of the brain and spinal cord are damaged and cause pain and loss of feeling in the affected areas. Professor Samuel Pfaff, first author Lydia Daboussi, and colleagues have now uncovered a mechanism in mice for repairing damaged nerves during peripheral neuropathy. The findings have the potential to inspire novel therapeutics that bolster repair functions and heal peripheral neuropathy caused by diabetes, injury, genetically inherited disease, infection, and more.

Read News Release

Nature Communications
12/2023

How drugs can target the thick “scar tissue” of pancreatic cancer

Pancreatic cancer is one of the deadliest cancers—only about one in eight patients survives five years after diagnosis. Those dismal statistics are in part due to the thick, nearly impenetrable wall of fibrosis, or scar tissue, that surrounds most pancreatic tumors and makes it hard for drugs to access and destroy the cancer cells. Professor Ronald Evans, Senior Staff Scientists Michael Downes and Annette Atkins, first author Gaoyang Liang, and colleagues have now discovered how a class of anti-cancer drugs called HDAC inhibitors can help treat pancreatic cancer by modulating the activation of fibroblasts—the cells that make up that wall of scar tissue.

Read News Release

Nature
12/2023

Assembling the first full epigenomic cell atlas of the mouse brain

In another NIH BRAIN Initiative collaboration of Salk colleagues and global collaborators, Professors Edward Callaway and Joseph Ecker and Research Professor Margarita Behrens worked together to publish four papers in a special feature in Nature with the goal of revolutionizing scientists’ understanding of the brain. The Salk team analyzed more than 2 million brain cells from mice to assemble the most complete mouse brain atlas ever. Altogether, the full 10-paper package details the thousands of cell types present in the mouse brain, how those cells connect, and which genes and regulatory programs are active in each cell.

Read News Release

Nature
01/2024

Iron influences plant immunity and may promote resiliency against climate change

Plants and animals alike rely on iron for growth and regulation of microbiomes—collections of bacteria, fungi, and more that coexist in places like the human gut or the soil around a plant’s roots. Plants face a special challenge when acquiring iron, since the strategies plants use to increase iron availability alter the root microbiome and can inadvertently benefit harmful soil-dwelling bacteria. Professor Wolfgang Busch, first author Min Cao, and colleagues have discovered how plants manage iron deficiency without helping “bad” bacteria thrive—by eliminating IMA1, the molecular signal for iron deficiency in roots at risk of bacterial attack. Additionally, they found that this iron deficiency signaling pathway and the plant immune system are deeply intertwined.

Read News Release

Nature Neuroscience
01/2024

Uncovering key brain pathway mediating panic disorder symptoms

Overwhelming fear, sweaty palms, shortness of breath, rapid heart rate—these are the symptoms of a panic attack, which people with panic disorder have frequently and unexpectedly. Creating a map of the regions, neurons, and connections in the brain that mediate these panic attacks can provide guidance for developing more effective panic disorder therapeutics. Now, Associate Professor Sung Han, co-first authors Sukjae Kang and Jong-Hyun Kim, and colleagues have begun to construct that map by discovering a brain circuit that mediates panic disorder. This circuit consists of specialized neurons that send and receive a neuropeptide—a small protein that sends messages throughout the brain—called PACAP. What’s more, they determined that PACAP and the neurons that produce its receptor are possible druggable targets for new panic disorder treatments.

Read News Release

Featured Stories

Support a legacy where cures begin.

Scientific discovery at the Salk Institute is made possible through your annual contributions. Your support will accelerate the pace of breakthroughs in understanding disease and pave the way to new drug therapies.
Get involved

Sign up for our monthly newsletter.

Latest discoveries, events & more.